Social Anxiety Disorder – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of social anxiety disorder comprises epidemiological estimates of key patient populations across seven countries worldwide. We report the prevalence of social anxiety disorder for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.
Clarivate Epidemiology’s social anxiety disorder forecast will answer the following questions:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of social anxiety disorder over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In total, Clarivate Epidemiology forecasts over two patient populations, as follows:
- SAD total 12-months prevalence.
- SAD total 12-months prevalence with comorbid major depressive disorder.
Note: coverage may vary by country.
